New MS Drug Does Not Appear to Increase COVID Severity

(MedPage Today) -- Multiple sclerosis (MS) patients treated with ofatumumab (Kesimpta) in an open-label extension study had non-serious cases of COVID-19 and recovered relatively quickly, researchers reported.
Of 139 relapsing-remitting MS patients...